Impact of progesterone receptor status on response to neoadjuvant chemotherapy in estrogen receptor-positive breast cancer patients. 2020

Michael R Boland, and Éanna J Ryan, and Timothy Nugent, and Darina Gilroy, and Michael E Kelly, and John Kennedy, and Aoife Maguire, and Dhafir Alazawi, and Terence J Boyle, and Elizabeth M Connolly
Department of Breast Surgery, St James' Hospital, Dublin, Ireland.

BACKGROUND Breast cancer patients respond differently to neoadjuvant chemotherapy(NAC) based on receptor subtype. The aim of this study was to assess the impact of progesterone receptor (PgR) status on response to neoadjuvant chemotherapy (NAC) in estrogen receptor (ER)+, human epidermal growth factor receptor (HER)- breast cancer patients. METHODS ER+ and HER- patients receiving NAC over a 7-year period (2011-2017) were identified. The primary outcome was breast complete pathological response (pCR) rate. Secondary outcomes included axillary pCR, axillary/breast pCR and complete radiological response (cRR). RESULTS A total of 203 patients were identified (149 in the ER+, PgR+, and HER- group and 54 in the ER+, PgR-, and HER- group). Compared with the PgR+ group, PgR- patients were significantly associated with breast pCR (31.5% vs 7.4%; χ² test; P < .01). In multivariable analysis, PgR- status (odds ratio [OR], 4.58; 95% confidence interval [CI]: 1.58,13.28; P = .005), radiological size >50 mm (OR, 5.38; 95% CI: 1.07,27.04; P = .04) and grade (OR, 3.52;95% CI: 1.21,10.23;P = .02) were significant predictors of breast pCR. Only PgR- status was a significant predictor of cRR (OR, 6.234; 95% CI: 2.531, 15.355; P < .001). In node positive patients, PgR negativity was associated with a trend towards breast/axillary nodal pCR (22% vs 12.7%; χ² test; P = .055). CONCLUSIONS Over 30% of ER+, PgR-, and HER- patients will have a breast pCR after NAC. PgR- is the only significant predictor of breast pCR/cRR in this tumor subtype. ER+, PgR-, and HER- patients should be considered for NAC.

UI MeSH Term Description Entries
D008137 Longitudinal Studies Studies in which variables relating to an individual or group of individuals are assessed over a period of time. Bogalusa Heart Study,California Teachers Study,Framingham Heart Study,Jackson Heart Study,Longitudinal Survey,Tuskegee Syphilis Study,Bogalusa Heart Studies,California Teachers Studies,Framingham Heart Studies,Heart Studies, Bogalusa,Heart Studies, Framingham,Heart Studies, Jackson,Heart Study, Bogalusa,Heart Study, Framingham,Heart Study, Jackson,Jackson Heart Studies,Longitudinal Study,Longitudinal Surveys,Studies, Bogalusa Heart,Studies, California Teachers,Studies, Jackson Heart,Studies, Longitudinal,Study, Bogalusa Heart,Study, California Teachers,Study, Longitudinal,Survey, Longitudinal,Surveys, Longitudinal,Syphilis Studies, Tuskegee,Syphilis Study, Tuskegee,Teachers Studies, California,Teachers Study, California,Tuskegee Syphilis Studies
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D011960 Receptors, Estrogen Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important. Estrogen Receptor,Estrogen Receptors,Estrogen Nuclear Receptor,Estrogen Receptor Type I,Estrogen Receptor Type II,Estrogen Receptors Type I,Estrogen Receptors Type II,Receptor, Estrogen Nuclear,Receptors, Estrogen, Type I,Receptors, Estrogen, Type II,Nuclear Receptor, Estrogen,Receptor, Estrogen
D011980 Receptors, Progesterone Specific proteins found in or on cells of progesterone target tissues that specifically combine with progesterone. The cytosol progesterone-receptor complex then associates with the nucleic acids to initiate protein synthesis. There are two kinds of progesterone receptors, A and B. Both are induced by estrogen and have short half-lives. Progesterone Receptors,Progestin Receptor,Progestin Receptors,Receptor, Progesterone,Receptors, Progestin,Progesterone Receptor,Receptor, Progestin
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Michael R Boland, and Éanna J Ryan, and Timothy Nugent, and Darina Gilroy, and Michael E Kelly, and John Kennedy, and Aoife Maguire, and Dhafir Alazawi, and Terence J Boyle, and Elizabeth M Connolly
June 2017, Journal of breast cancer,
Michael R Boland, and Éanna J Ryan, and Timothy Nugent, and Darina Gilroy, and Michael E Kelly, and John Kennedy, and Aoife Maguire, and Dhafir Alazawi, and Terence J Boyle, and Elizabeth M Connolly
December 2011, Breast (Edinburgh, Scotland),
Michael R Boland, and Éanna J Ryan, and Timothy Nugent, and Darina Gilroy, and Michael E Kelly, and John Kennedy, and Aoife Maguire, and Dhafir Alazawi, and Terence J Boyle, and Elizabeth M Connolly
October 2003, American journal of surgery,
Michael R Boland, and Éanna J Ryan, and Timothy Nugent, and Darina Gilroy, and Michael E Kelly, and John Kennedy, and Aoife Maguire, and Dhafir Alazawi, and Terence J Boyle, and Elizabeth M Connolly
January 2024, Diagnostic pathology,
Michael R Boland, and Éanna J Ryan, and Timothy Nugent, and Darina Gilroy, and Michael E Kelly, and John Kennedy, and Aoife Maguire, and Dhafir Alazawi, and Terence J Boyle, and Elizabeth M Connolly
January 2021, Gland surgery,
Michael R Boland, and Éanna J Ryan, and Timothy Nugent, and Darina Gilroy, and Michael E Kelly, and John Kennedy, and Aoife Maguire, and Dhafir Alazawi, and Terence J Boyle, and Elizabeth M Connolly
October 2008, Breast (Edinburgh, Scotland),
Michael R Boland, and Éanna J Ryan, and Timothy Nugent, and Darina Gilroy, and Michael E Kelly, and John Kennedy, and Aoife Maguire, and Dhafir Alazawi, and Terence J Boyle, and Elizabeth M Connolly
January 2010, The breast journal,
Michael R Boland, and Éanna J Ryan, and Timothy Nugent, and Darina Gilroy, and Michael E Kelly, and John Kennedy, and Aoife Maguire, and Dhafir Alazawi, and Terence J Boyle, and Elizabeth M Connolly
December 1980, Cancer,
Michael R Boland, and Éanna J Ryan, and Timothy Nugent, and Darina Gilroy, and Michael E Kelly, and John Kennedy, and Aoife Maguire, and Dhafir Alazawi, and Terence J Boyle, and Elizabeth M Connolly
January 2020, PloS one,
Michael R Boland, and Éanna J Ryan, and Timothy Nugent, and Darina Gilroy, and Michael E Kelly, and John Kennedy, and Aoife Maguire, and Dhafir Alazawi, and Terence J Boyle, and Elizabeth M Connolly
August 2011, Zhonghua yi xue za zhi,
Copied contents to your clipboard!